Literature DB >> 21321396

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions.

Minerva M Carrasquillo1, Olivia Belbin, Talisha A Hunter, Li Ma, Gina D Bisceglio, Fanggeng Zou, Julia E Crook, V Shane Pankratz, Sigrid B Sando, Jan O Aasly, Maria Barcikowska, Zbigniew K Wszolek, Dennis W Dickson, Neill R Graff-Radford, Ronald C Petersen, Kevin Morgan, Steven G Younkin.   

Abstract

The most recent late-onset Alzheimer's disease (LOAD) genome-wide association study revealed genome-wide significant association of two new loci: rs744373 near BIN1 (p = 1.6 × 10-11) and rs597668 near EXOC3L2/BLOC1S3/MARK4 (p = 6.5 × 10-9). We have genotyped these variants in a large (3,287 LOAD, 4,396 controls), independent dataset comprising eleven case-control series from the USA and Europe. We performed meta-analyses of the association of these variants with LOAD and also tested for association using logistic regression adjusted by age-at-diagnosis, gender, and APOE ε4 status. Meta-analysis results showed no evidence of series heterogeneity and logistic regression analysis successfully replicated the association of BIN1 (rs744373) with LOAD with an odds ratio (OR = 1.17, p = 1.1 × 10-4) comparable to that previously reported (OR = 1.15). The variant near EXOC3L2 (rs597668) showed only suggestive association with LOAD (p = 0.09) after correcting for the presence of the APOE ε4 allele. Addition of our follow-up data to the results previously reported increased the strength of evidence for association with BIN1 (11,825 LOAD, 32,570 controls, rs744373 Fisher combined p = 3.8 × 10-20). We also tested for epistatic interaction between these variants and APOE ε4 as well as with the previously replicated LOAD GWAS genes (CLU: rs11136000, CR1: rs3818361, and PICALM: rs3851179). No significant interactions between these genes were detected. In summary, we provide additional evidence for the variant near BIN1 (rs744373) as a LOAD risk modifier, but our results indicate that the effect of EXOC3L2 independent of APOE ε4 should be studied further.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321396      PMCID: PMC3489170          DOI: 10.3233/JAD-2011-101932

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

2.  Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.

Authors:  Jean-Charles Lambert; Diana Zelenika; Mikko Hiltunen; Vincent Chouraki; Onofre Combarros; Maria J Bullido; Gloria Tognoni; Nathalie Fiévet; Anne Boland; Beatrice Arosio; Eliecer Coto; Maria Del Zompo; Ignacio Mateo; Ana Frank-Garcia; Seppo Helisalmi; Elisa Porcellini; Alberto Pilotto; Paola Forti; Raffaele Ferri; Marc Delepine; Elio Scarpini; Gabriele Siciliano; Vincenzo Solfrizzi; Sandro Sorbi; Gianfranco Spalletta; Giovanni Ravaglia; Fernando Valdivieso; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Paola Piccardi; Giorgio Annoni; Davide Seripa; Daniela Galimberti; Federico Licastro; Mark Lathrop; Hilkka Soininen; Philippe Amouyel
Journal:  Neurobiol Aging       Date:  2011-01-08       Impact factor: 4.673

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Authors:  Jean-Charles Lambert; Simon Heath; Gael Even; Dominique Campion; Kristel Sleegers; Mikko Hiltunen; Onofre Combarros; Diana Zelenika; Maria J Bullido; Béatrice Tavernier; Luc Letenneur; Karolien Bettens; Claudine Berr; Florence Pasquier; Nathalie Fiévet; Pascale Barberger-Gateau; Sebastiaan Engelborghs; Peter De Deyn; Ignacio Mateo; Ana Franck; Seppo Helisalmi; Elisa Porcellini; Olivier Hanon; Marian M de Pancorbo; Corinne Lendon; Carole Dufouil; Céline Jaillard; Thierry Leveillard; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Paola Piccardi; Giorgio Annoni; Davide Seripa; Daniela Galimberti; Didier Hannequin; Federico Licastro; Hilkka Soininen; Karen Ritchie; Hélène Blanché; Jean-François Dartigues; Christophe Tzourio; Ivo Gut; Christine Van Broeckhoven; Annick Alpérovitch; Mark Lathrop; Philippe Amouyel
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

5.  The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study.

Authors:  A L Bergem; K Engedal; E Kringlen
Journal:  Arch Gen Psychiatry       Date:  1997-03

6.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

7.  Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.

Authors:  A Klimkowicz-Mrowiec; M Marona; P Wołkow; A Maruszak; M Styczynska; M Barcikowska; C Zekanowski; A Szczudlik; A Slowik
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-20       Impact factor: 2.959

8.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Fanggeng Zou; V Shane Pankratz; Samantha L Wilcox; Li Ma; Louise P Walker; Samuel G Younkin; Curtis S Younkin; Linda H Younkin; Gina D Bisceglio; Nilufer Ertekin-Taner; Julia E Crook; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

9.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Authors:  Eric M Reiman; Jennifer A Webster; Amanda J Myers; John Hardy; Travis Dunckley; Victoria L Zismann; Keta D Joshipura; John V Pearson; Diane Hu-Lince; Matthew J Huentelman; David W Craig; Keith D Coon; Winnie S Liang; RiLee H Herbert; Thomas Beach; Kristen C Rohrer; Alice S Zhao; Doris Leung; Leslie Bryden; Lauren Marlowe; Mona Kaleem; Diego Mastroeni; Andrew Grover; Christopher B Heward; Rivka Ravid; Joseph Rogers; Michael L Hutton; Stacey Melquist; Ron C Petersen; Gene E Alexander; Richard J Caselli; Walter Kukull; Andreas Papassotiropoulos; Dietrich A Stephan
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

10.  APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Authors:  Sigrid B Sando; Stacey Melquist; Ashley Cannon; Michael L Hutton; Olav Sletvold; Ingvild Saltvedt; Linda R White; Stian Lydersen; Jan O Aasly
Journal:  BMC Neurol       Date:  2008-04-16       Impact factor: 2.474

View more
  34 in total

1.  p53 prevents neurodegeneration by regulating synaptic genes.

Authors:  Paola Merlo; Bess Frost; Shouyong Peng; Yawei J Yang; Peter J Park; Mel Feany
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

2.  Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Julia E Crook; Otto Pedraza; Colleen S Thomas; V Shane Pankratz; Mariet Allen; Thuy Nguyen; Kimberly G Malphrus; Li Ma; Gina D Bisceglio; Rosebud O Roberts; John A Lucas; Glenn E Smith; Robert J Ivnik; Mary M Machulda; Neill R Graff-Radford; Ronald C Petersen; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  Neurobiol Aging       Date:  2014-08-04       Impact factor: 4.673

3.  Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype.

Authors:  Madhav Thambisetty; Yang An; Michael Nalls; Jitka Sojkova; Shanker Swaminathan; Yun Zhou; Andrew B Singleton; Dean F Wong; Luigi Ferrucci; Andrew J Saykin; Susan M Resnick
Journal:  Biol Psychiatry       Date:  2012-09-27       Impact factor: 13.382

4.  Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD.

Authors:  Minerva M Carrasquillo; Qurat ul Ain Khan; Melissa E Murray; Siddharth Krishnan; Jeremiah Aakre; V Shane Pankratz; Thuy Nguyen; Li Ma; Gina Bisceglio; Ronald C Petersen; Steven G Younkin; Dennis W Dickson; Bradley F Boeve; Neill R Graff-Radford; Nilüfer Ertekin-Taner
Journal:  Neurology       Date:  2014-03-26       Impact factor: 9.910

Review 5.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

6.  Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.

Authors:  Stephanie L Adams; Kathy Tilton; James A Kozubek; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-26       Impact factor: 3.685

7.  Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.

Authors:  Lior Greenbaum; Ramit Ravona-Springer; Irit Lubitz; James Schmeidler; Itzik Cooper; Mary Sano; Jeremy M Silverman; Anthony Heymann; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2015-11-14       Impact factor: 4.600

8.  Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative.

Authors:  Shashwath A Meda; Mary Ellen I Koran; Jennifer R Pryweller; Jennifer N Vega; Tricia A Thornton-Wells
Journal:  Neurobiol Aging       Date:  2012-10-27       Impact factor: 4.673

Review 9.  Amphiphysin 2 (BIN1) in physiology and diseases.

Authors:  Ivana Prokic; Belinda S Cowling; Jocelyn Laporte
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

10.  Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?

Authors:  C Ma; Y Zhang; X Li; J Zhang; K Chen; Y Liang; Y Chen; Z Liu; Z Zhang
Journal:  Eur J Neurol       Date:  2016-06-04       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.